NeuroMetrix, Inc.
NURO · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -0.8% | -23.6% | -29.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | 61.6% | 53.1% | 64% | 47.3% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $2 | $1 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $4 |
| Operating Income | -$2 | -$2 | -$2 | -$3 |
| % Margin | -335.8% | -296.6% | -237.8% | -297.6% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$2 | -$2 | -$1 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$2 | -$1 | -$3 |
| % Margin | -305.5% | -256.8% | -193.5% | -277% |
| EPS | -0.87 | -0.75 | -0.74 | -1.67 |
| % Growth | -16% | -1.4% | 55.7% | – |
| EPS Diluted | -0.87 | -0.75 | -0.74 | -1.67 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$2 | -$3 |
| % Margin | -295.8% | -286.4% | -225.8% | -295.3% |